<p><b>A.</b> Percentage of PB/PCs circulating in the blood of patients suspected of DENV infection. Mean and SE of the percentage of PB/PCs among total lymphocytes plotted according to day post-onset of symptoms. As the same patient may have had up to 3 samples processed, the patient may be represented more than once over time. The number of samples processed is shown below the graph. The percentage of PB/PCs increased over time in DENV-positive samples and peaked at day 5 post-onset of symptoms. Statistical analysis was performed using the Mann-Whitney test, and a significant difference in percentage of PB/PC between OFIs and DENV-positive cases was found at day 5 post-onset of symptoms. The p-value is shown below the symbol legend. <b>B.<...
<p><b>A.</b> IgG serum avidity to DENV3 day 14–28 (convalescent), 3 m, 6 m and 18 m post-onset of sy...
<p>PBMCs were infected with DENV2-eGFP in the presence of 4G2 antibody (1 μg/ml). Top row: Monocytes...
<p>(A) The correlation between the percentage of infected cells determined by intracellular staining...
<p>The mean of relative proportion (%) of mDCs, pDCs, and DN were analyzed in blood samples from 68 ...
<p><b>A.</b> Phenotype of circulating B cells in patients suspected of DENV infection. Whole blood w...
<p>(A) Representative histogram plots showing expression of the potential maturation markers on pDCs...
<p>(A) Representative histogram plots showing maturation markers on mDCs on blood samples from healt...
<p>Distribution of each of the three mDC subsets as a percentage of total DCs during acute DENV was ...
<p><b>A.</b> DENV-specific IgG serum avidity at convalescence in 1° DENV-3 infections. Convalescent ...
<p>The kinetics of the relative proportion of mDCs (A), pDCs (B), DN (C), CD16<sup>+</sup> mDCs (D),...
<p>Several cell populations (pDCs, B cells, cDCs, Monocytes and MDDCs) were isolated from human bloo...
<p>Plasma and PBMC cell subpopulations of 11 primary and 15 secondary DENV infections, all of whom h...
<p><b>A)</b> PBMCs or purified B cells were mock-treated or cultured with DENV2. After 12 days p.i.,...
<p><b>A.</b> DENV-specific neutralization of the serum at 3 months post-onset of symptoms in 2° DENV...
<p><b>A.</b> DENV3-specific NT<sub>50</sub> of serum day 4–6 (acute), day 14–28 (convalescent), 3 m,...
<p><b>A.</b> IgG serum avidity to DENV3 day 14–28 (convalescent), 3 m, 6 m and 18 m post-onset of sy...
<p>PBMCs were infected with DENV2-eGFP in the presence of 4G2 antibody (1 μg/ml). Top row: Monocytes...
<p>(A) The correlation between the percentage of infected cells determined by intracellular staining...
<p>The mean of relative proportion (%) of mDCs, pDCs, and DN were analyzed in blood samples from 68 ...
<p><b>A.</b> Phenotype of circulating B cells in patients suspected of DENV infection. Whole blood w...
<p>(A) Representative histogram plots showing expression of the potential maturation markers on pDCs...
<p>(A) Representative histogram plots showing maturation markers on mDCs on blood samples from healt...
<p>Distribution of each of the three mDC subsets as a percentage of total DCs during acute DENV was ...
<p><b>A.</b> DENV-specific IgG serum avidity at convalescence in 1° DENV-3 infections. Convalescent ...
<p>The kinetics of the relative proportion of mDCs (A), pDCs (B), DN (C), CD16<sup>+</sup> mDCs (D),...
<p>Several cell populations (pDCs, B cells, cDCs, Monocytes and MDDCs) were isolated from human bloo...
<p>Plasma and PBMC cell subpopulations of 11 primary and 15 secondary DENV infections, all of whom h...
<p><b>A)</b> PBMCs or purified B cells were mock-treated or cultured with DENV2. After 12 days p.i.,...
<p><b>A.</b> DENV-specific neutralization of the serum at 3 months post-onset of symptoms in 2° DENV...
<p><b>A.</b> DENV3-specific NT<sub>50</sub> of serum day 4–6 (acute), day 14–28 (convalescent), 3 m,...
<p><b>A.</b> IgG serum avidity to DENV3 day 14–28 (convalescent), 3 m, 6 m and 18 m post-onset of sy...
<p>PBMCs were infected with DENV2-eGFP in the presence of 4G2 antibody (1 μg/ml). Top row: Monocytes...
<p>(A) The correlation between the percentage of infected cells determined by intracellular staining...